Página de Busca


Filtros correntes:
Retornar valores
Adicionar filtros:

Utilizar filtros para refinar o resultado de busca.


Resultado 1-5 de 5.
  • Anterior
  • 1
  • Póximo
Conjunto de itens:
Pré-visualizaçãoData do documentoTítuloAutor(es)
Quality of Life and Adverse Effects of Olanzapine_2013.pdf.jpg18-Jul-2012Quality of life and adverse effects of olanzapine versus risperidone therapy in patients with schizophreniaAraújo, Aurigena Antunes de; Chaves, Katarina Melo; Serrano-Blanco, Antoni; Ribeiro, Susana Barbosa; Soares, Luiz Alberto Lira; Guerra, Gerlane Coelho Bernardo; Alves, Maria do Socorro Costa Feitosa; Araújo Júnior, Raimundo Fernandes de; Rachetti, Vanessa de Paula Soares; Filgueira Júnior, Antônio
Quality of Life and Hormonal_2015.pdf.jpgJun-2016Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone UsersAraújo, Aurigena Antunes de; Ribeiro, Susana Barbosa; Santos, Ana Cely Souza dos; Lemos, Telma Maria Araújo Moura; Medeiros, Caroline Addison Xavier; Guerra, Gerlane Coelho Bernardo; Araújo Júnior, Raimundo Fernandes de; Serrano-Blanco, Antoni; Rubio-Valera, Maria
Quality of Life in Patients with Schizophrenia_2014.pdf.jpg1-Mai-2014Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics DrugsAraújo, Aurigena Antunes de; Dantas, Diego de Araújo; Nascimento, Gemma Galgani do; Ribeiro, Susana Barbosa; Chaves, Katarina Melo; Silva, Vanessa de Lima; Araújo Jr., Raimundo Fernandes de; Souza, Dyego Leandro Bezerra de; Medeiros, Caroline Addison Carvalho Xavier de
Factors associated with expression of extrapyramidal _2016.pdf.jpg26-Nov-2016Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychoticsAraújo, Aurigena Antunes de; Ribeiro, Susana Barbosa; Medeiros, Caroline Addison Xavier; Chaves, Katarina Melo; Alves, Maria do Socorro Costa Feitosa; Oliveira, Antonio Gouveia; Martins, Rand Randall
Targeting the NMDA receptor-nitric oxide-cyclic_2011.pdf.jpgSet-2011Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophreniaSoares, Bruno Lobão; Oliveira, João Paulo Maia de; Machado-de-Sousa, João Paulo; Baker, Glen B.; Dursun, Serdar; Hallak, Jaime E. C.